Does declining ovarian estradiol in menopause cause elevated FSH and LH?

The hormonal shifts of menopause are defined by a fundamental change in the hypothalamic-pituitary-ovarian (HPO) axis, where the loss of ovarian endocrine output triggers a profound physiological recalibration.

Clinical and effectiveness evidence

In women of reproductive age, the pituitary gland’s secretion of gonadotropins—follicle-stimulating hormone (FSH) and luteinizing hormone (LH)—is tightly regulated by ovarian hormones. During the menopausal transition, as the ovarian follicle pool becomes exhausted, estradiol (E2) levels drop significantly, often falling from a mean of approximately 81 pg/ml in premenopausal states to consistently below 30–40 pg/ml in postmenopause.

Clinical data consistently demonstrate that this decline leads to a massive elevation in gonadotropins:

• FSH levels typically increase 10- to 15-fold, often exceeding 30 IU/L and reaching levels as high as 140 mIU/mL.
• LH levels experience a similar, though slightly less pronounced, rise of approximately 3- to 8-fold.
• Temporal stability: While these hormones peak roughly 5 to 7 years after the final menstrual period, they remain significantly elevated even in late postmenopause (age 70+), though a slight age-related attenuation in pituitary sensitivity to GnRH may occur in the eighth decade of life.

Mechanistic explanations

The elevation of FSH and LH is driven by the withdrawal of estradiol-mediated negative feedback. Mechanistically, estradiol normally binds to estrogen receptor alpha (ERα) located on pituitary gonadotropes. This binding inhibits the transcription and secretion of the gonadotropin subunits.

As ovarian estradiol production ceases:

• Disinhibition: The inhibitory signal on the pituitary is lost, leading to increased mRNA expression for the FSH and LH subunits.
• GnRH Pulse Frequency: Reduced estradiol also affects the hypothalamus, leading to an increase in the frequency and amplitude of gonadotropin-releasing hormone (GnRH) pulses, which further drives pituitary gonadotropin production.
• Loss of Inhibin: In addition to estradiol, the loss of ovarian Inhibin B specifically removes a critical brake on FSH secretion, contributing to why FSH typically rises earlier and more dramatically than LH.

Bottom line

The claim is robustly supported: the decline in ovarian estradiol during menopause removes the essential negative feedback on the pituitary gland, leading to a persistent and significant elevation of FSH and LH that continues throughout the postmenopausal years.